Alogliptin and Pioglitazone

NDC 45802-260 · Padagis Israel Pharmaceuticals Ltd

Generic nameAlogliptin Benzoate and Pioglitazone hydrochloride

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Strength12.5; 30 mg/1; mg/1

Pharmacologic classDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryNDA AUTHORIZED GENERIC

Packages

45802-260-65 — 30 TABLET, FILM COATED in 1 BOTTLE (45802-260-65)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-176 — Pioglitazone and metformin hydrochloride, 33342-177 — Pioglitazone and metformin hydrochloride, 42291-959 — Pioglitazone, 42291-960 — Pioglitazone, 42291-961 — Pioglitazone, 45802-087 — Alogliptin, 45802-103 — Alogliptin, 45802-150 — Alogliptin, 45802-169 — alogliptin and metformin hydrochloride, 45802-211 — alogliptin and metformin hydrochloride, 45802-351 — Alogliptin Benzoate and Pioglitazone hydrochloride, 45802-402 — Alogliptin Benzoate and Pioglitazone hydrochloride, 45802-499 — Alogliptin Benzoate and Pioglitazone hydrochloride, 50090-4605 — Pioglitazone, 50090-5574 — Alogliptin, 50090-5993 — alogliptin and metformin hydrochloride, 50090-6384 — pioglitazone hydrochloride, 50090-6386 — pioglitazone hydrochloride, 50090-6393 — pioglitazone hydrochloride, 50090-6412 — Pioglitazone, +83 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.